Maunsell Farris Maryanne bought HAE
May 15, 2026 · Form 4 insider transaction
Maunsell Farris Maryanne bought 2,220 shares of Haemonetics Corporation, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
2,220
Price
N/A
Total value
N/A
InsiderMaunsell Farris Maryanne
Role—
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateMay 15, 2026
Filing dateMay 19, 2026
Shares owned after6,501
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The securities awarded are in the form of RSUs issued pursuant to the Haemonetics Corporation Amended and Restated 2019 Long-Term Incentive Compensation Plan. The RSUs vest in three equal annual installments beginning on the first anniversary of the date of grant.; Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested.; This number includes unvested RSUs previously reported.